Latest Asx Companies News

ASX has suspended 15 listed companies from quotation after they failed to lodge required periodic reports by their deadlines. Trading may resume quickly if the outstanding reports are lodged, but the announcement gives no detail on the cause or length of each delay.

Hastings Technology Metals has cut its annual loss sharply, but its latest report flags a material uncertainty over whether the pre-production rare earths company can secure the funding needed for Yangibana and its proposed Thai processing plant. The uncertainty comes as Wyloo seeks to sell its 60% Yangibana stake despite a study showing attractive project economics.

PDI Gold’s first full annual report after its Robex merger shows a transformed West African gold business with US$193.7 million in cash and two producing mines. The statutory result remains a US$63.7 million loss, while Bankan’s next phase still depends on an exploitation permit from Guinea.

Argent BioPharma has secured exclusive commercialisation rights to selected Tollovir, Tollovid and NutraVir antiviral products in a worldwide deal excluding China. The agreement adds a new commercial pillar alongside CimetrA®, but does not itself grant pharmaceutical development rights or establish clinical efficacy.

Navigator Global Investments expects to receive USD40-43 million upfront after New York Life Investment Management agrees to acquire 60% of Invictus Capital Partners. The deal crystallises value from NGI’s 2022 investment while leaving shareholders exposed to earn-outs, distributions and a second sale in 2031.

Titomic has set 30 November 2026 as its current target to complete a proposed move of its parent company from Australia to the United States. The ASX listing would remain, but investors would hold CHESS Depositary Interests in the new US entity if shareholders, the Court and other conditions approve the scheme.

Elixinol Wellness will acquire personalised supplement platform Vitable for headline consideration of A$2.5 million in shares, adding recurring revenue and more than 7,850 active subscribers. The deal could lift combined revenue to A$27 million by 2028, but remains subject to shareholder approval and carries meaningful dilution risk.

Critica Limited (ASX:CRI) has delivered stronger technical results across its Jupiter rare earths and Mt Lindsay tin-tungsten projects, but the developer remains dependent on further funding. Two scoping studies targeted for Q3 2026 now carry the burden of translating resource potential and laboratory results into project economics.

Vection Technologies has signed reciprocal five-year reseller agreements with Xerox, opening a potential Western European channel for its conversational AI, digital human, kiosk and XR technologies. The opportunity is strategically notable, but the agreements contain no minimum volumes, pricing or committed revenue.

Streamplay’s Noodlecake Studios has secured the mobile publishing rights to Space Warlord Baby Trading Simulator, adding a distinctive PC and console title to its pipeline. The iOS and Android release is targeted for Q1 2027, but revenue terms and launch outcomes remain undisclosed.

Rox Resources is pitching Youanmi as a fully funded, near-term gold producer while outlining an ambition to lift output beyond 150,000 ounces a year. The mine’s initial plan remains materially smaller, with first gold targeted for mid-2027 and average production of about 117,000 ounces a year.

Antimony Resources has begun trading under the ANT code as its Tecomatlán processing plant in Mexico moves closer to its first processing campaign. About 200 tonnes of mineralised material has been prepared, but assay results and commissioning outcomes are still to come.